GRGTEST(SZ:002967) Xin Lang Cai Jing·2025-10-25 10:36Core Insights - The company's profitability continues to improve, with net profit margins recovering quarter by quarter, and profit growth consistently outpacing revenue growth [1][3] Financial Performance - For the first three quarters of 2025, the company achieved operating revenue of 2.416 billion yuan, a year-on-year increase of 11.86%, and a net profit attributable to shareholders of 239 million yuan, up 26.51% year-on-year [2] - In Q3 2025, the company reported operating revenue of 938 million yuan, a year-on-year increase of 14.91%, and a net profit attributable to shareholders of 142 million yuan, up 29.73% year-on-year [2] - The gross margin and net margin for Q1-Q3 2025 were 45.06% and 9.84%, respectively, with year-on-year increases of 0.52 percentage points and 1.30 percentage points [3] - The Q3 2025 gross margin was 47.74%, with a year-on-year decrease of 1.16 percentage points, while the net margin was 15.51%, up 2.03 percentage points year-on-year [3] Cost Structure and Cash Flow - The expense ratio for Q1-Q3 2025 was 34.99%, a year-on-year decrease of 0.41 percentage points, with specific expense ratios for sales, management, finance, and R&D showing varied changes [3] - Operating net cash flow for Q1-Q3 2025 was 258 million yuan, a year-on-year decrease of 23.42%, primarily due to the impact of collection timing [3] Strategic Initiatives - The company plans to raise no more than 1.3 billion yuan through a private placement, focusing on high-growth emerging industries such as aviation, AI chips, and satellite internet [4] - This strategic move aims to enhance the company's high-end testing capabilities, covering the entire chain from R&D validation to reliability testing and quantitative measurement [4] - The expansion of laboratory capabilities in key regions like Guangzhou, Chengdu, and Xi'an is expected to strengthen the company's service and bargaining power in strategic emerging industries [4]